Circulate Health, Inc. — Form D/A
Circulate Health, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2026-01-09. The offering totals $13.0M, of which $13.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-09
- Form: D/A
- Accession: 0002078196-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $13.0M
- Investors: 4
- Date of first sale: 2025-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561676
Issuer
- Name: Circulate Health, Inc.
- CIK: 0002078196
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1424 11TH AVE STE 400, SEATTLE, WA, 98122
- Phone: 206-289-0097
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Brad Younggren | Director | Seattle, WA |
| Brad Younggren | Executive Officer | Seattle, WA |
| Brad Younggren | Promoter | Seattle, WA |
| Uri Greenwald | Director | Seattle, WA |
| Robbie Schwietzer | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More